0001755672-26-000004
SEC filingEIDP, Inc. reported strong financial results for fiscal year 2025, with net sales of $17.40 billion and net income attributable to the company of $1.09 billion. The company generated $3.41 billion in cash from operating activities, demonstrating robust cash generation capabilities. Key profitability metrics include income from continuing operations before taxes of $1.69 billion and basic earnings per share of $2.00. The balance sheet shows total assets of $42.84 billion, with $4.52 billion in cash and cash equivalents, and total equity of $24.39 billion. The company maintained significant investments in research and development ($1.47 billion) while managing costs effectively, resulting in solid operational performance for the fiscal year.
EIDP, Inc. delivered solid financial performance for fiscal year 2025, reporting net sales of $17.40 billion and net income attributable to the company of $1.09 billion. The company generated income from continuing operations before income taxes of $1.69 billion, with a provision for income taxes on continuing operations of $484 million. Basic and diluted earnings per share both stood at $2.00. Cash flow from operating activities was strong at $3.41 billion, while investing activities used $543 million and financing activities used $1.64 billion. The company ended the period with $4.52 billion in cash and cash equivalents, representing a solid liquidity position.
Revenue analysis for EIDP, Inc. shows net sales of $17.40 billion for fiscal year 2025. The company's cost of goods sold was $9.17 billion, resulting in gross profit of $8.23 billion. No segment breakdown or geographic mix information was provided in the available data. The company maintained significant investment in research and development at $1.47 billion, while selling, general and administrative expenses totaled $3.49 billion. Other income (expense) - net showed a negative $570 million, primarily impacting the overall profitability.
EIDP, Inc. achieved a gross margin of 47.3% based on net sales of $17.40 billion and cost of goods sold of $9.17 billion. The company's operating expenses included research and development ($1.47 billion), selling, general and administrative ($3.49 billion), amortization of intangibles ($644 million), restructuring and asset related charges ($146 million), and business separation costs ($35 million). These expenses, combined with other income (expense) of -$570 million and interest expense of $180 million, resulted in income from continuing operations before income taxes of $1.69 billion. The effective tax rate on continuing operations was approximately 28.6%.
Cash flow performance was strong with $3.41 billion generated from operating activities. Free cash flow, calculated as operating cash flow ($3.41 billion) minus capital expenditures ($591 million), was $2.82 billion. The balance sheet shows total assets of $42.84 billion, including current assets of $17.34 billion and net property, plant and equipment of $4.22 billion. Total liabilities were $18.45 billion, consisting of current liabilities of $12.12 billion and noncurrent liabilities of $6.33 billion. Total equity stood at $24.39 billion, with stockholders' equity attributable to the company of $24.14 billion. The company maintained $1.69 billion in long-term debt.
No specific management guidance, strategic priorities, or forward-looking statements were provided in the available financial data. The filing presents historical financial results for fiscal year 2025 without explicit discussion of future expectations or risk factors. Investors should refer to the complete 10-K filing for comprehensive disclosure of management's discussion and analysis, including any forward-looking statements, strategic initiatives, or identified risk factors that may impact future performance.